Table 3 Integrated discrimination improvement and net reclassification improvement for pulse pressure amplification
From: An outcome-driven threshold for pulse pressure amplification
Cohort Endpoint Risk indicator | Integrated discrimination improvement | Net reclassification improvement | ||
---|---|---|---|---|
IDI (%) | P | NRI (%) | P | |
Discovery (n = 3945) | ||||
Cardiovascular | ||||
PPA < 1.3 vs ≥1.3 | 0.12 (−0.25, 0.50) | 0.52 | 16.1 (1.73, 30.5) | 0.028 |
Continuous | 0.27 (−0.15, 0.69) | 0.21 | 9.26 (−5.29, 23.8) | 0.21 |
Coronary | ||||
PPA < 1.3 vs ≥1.3 | 0.41 (−0.41,1.22) | 0.33 | 33.0 (11.9, 54.2) | 0.002 |
Continuous | 0.40 (−0.47, 1.27) | 0.36 | 21.6 (−0.41, 43.7) | 0.054 |
Replication (n = 1663) | ||||
Cardiovascular | ||||
PPA < 1.3 vs ≥1.3 | 0.50 (−0.72, 1.71) | 0.42 | 33.7 (10.0, 57.4) | 0.005 |
Continuous | 0.76 (−0.35, 1.88) | 0.18 | 22.7 (−1.74, 47.1) | 0.069 |
Coronary | ||||
PPA < 1.3 vs ≥1.3 | 0.89 (−2.08, 3.85) | 0.56 | 44.9 (11.7, 78.2) | 0.008 |
Continuous | 1.08 (−0.60, 2.76) | 0.21 | 30.2 (−4.45, 64.8) | 0.088 |
All (n = 5608) | ||||
Cardiovascular | ||||
PPA < 1.3 vs ≥1.3 | 0.16 (−0.20, 0.53) | 0.38 | 15.2 (2.76, 27.6) | 0.017 |
Continuous | 0.29 (−0.10, 0.68) | 0.15 | 11.8 (−0.70, 24.3) | 0.064 |
Coronary | ||||
PPA < 1.3 vs ≥1.3 | 0.49 (−0.37, 1.34) | 0.26 | 30.8 (12.7,48.9) | 0.001 |
Continuous | 0.46 (−0.28, 1.21) | 0.22 | 21.5 (2.85, 40.2) | 0.024 |